Intrathecal hydromorphone for chronic nomalignant pain: A retrospective study

Pain Medicine

Volumn 2, Issue 4, 2001, Pages 287-297

  Anderson, Valerie C ^a,b   Cooke, Beverly ^a   Burchiel, Kim J ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Analgesia; Chronic pain; Hydromorphone; Intrathecal; Opioids

Indexed keywords

HYDROMORPHONE; MORPHINE; OPIATE;

ADULT; AGED; ANALGESIA; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG EFFICACY; DRUG EXPOSURE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; EDEMA; FEMALE; HUMAN; LONG TERM CARE; LUMBOSACRAL SPINE; MALE; NAUSEA AND VOMITING; PAIN ASSESSMENT; PRURITUS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEDATION; SPINE SURGERY; TREATMENT FAILURE;

EID: 0035696752     PISSN: 15262375     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4637.2001.01052.x     Document Type: Article

References (59)

1. Morphine and hydromorphone epidural analgesia. A prospective randomized comparison
2. Advances in cancer pain
3. Solubility and related physicochemical properties of narcotic analgesics
4. Accuracy in equianalgesic dosing: Conversion dilemmas
5. Opioid rotation in patients with cancer pain: A retrospective comparison of dose rotations between methadone, hydromorphone and morphine
6. Dose ratio between morphine and hydromorphone in patients with cancer pain: A retrospective study
7. Mechanisms of the analgesic actions of opiates and opioids
8. Multiple-dose evaluation of intravenous hydromorphone pharmacokinetics in normal human subjects
9. Continuous subcutaneous infusion of morphine vs. hydromorphone: A controlled trial
10. Alternate routes of administration of opioids for the management of cancer pain
11. A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain
12. Current practices in intraspinal therapy: A survey of clinical trends and decision making
13. The state of implantable pain therapies in the United States: A nationwide survey of academic teaching programs
14. Clinical realities and economic considerations: Efficacy of intrathecal pain therapy
15. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology
16. Current pharmacotherapy of chronic pain
17. Long-term opioid therapy: Assessment of consequences and risks
18. Side effects of intrathecal and epidural opioids
19. Evidence-based review of the literature on intrathecal delivery of pain medication
20. Intraspinal morphine for chronic pain: A retrospective, multicenter study
21. Opioid rotation for cancer pain: Rationale and clinical aspects
22. Dose ratio between morphine and methadone in patients with cancer pain: A retrospective study
23. Comparison of epidural morphine, hydromorphone and fentanyl for postoperative pain control in children undergoing orthopaedic surgery
24. Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration?
25. Chronic nausea and morphine-6-glucuronide
26. Disappearance of morphine-induced hyperalgesia after discontinuing or substituting with other opioid agonists
27. Clinical analgesic studies of hydromorphone
28. Intrathecal infusional therapies for intractable pain: Patient management guidelines
29. New clinical-practice guidelines for the management of pain in patients with cancer
30. Opioid hyperexcitability: The application of alternative opioid therapy
31. Opioid rotation for toxicity reduction in terminal cancer patients
32. Continuous intrathecal hydromorphone and clonidine for intractable cancer pain
33. Epidural and subarachnoid administration of opioids for nonmalignant pain: Technical issues, current approaches and novel treatments
34. Clinical guidelines for intraspinal infusion: Report of an expert panel
35. Efficacy and technical complications of long-term continuous intraspinal infusions of opioid and/or bupivacaine in refractory nonmalignant pain: A comparison between the epidural and the intrathecal approach with implanted catheters and infusion pumps
36. Intrathecal infusional analgesia for nonmalignant pain: Analgesic efficacy of intrathecal opioid with or without bupivacaine
37. Long-term intrathecal morphine and bupivacaine in "refractory" Cancer pain: I. Results from the first series of 52 patients
38. Sufentanil citrate and morphine/bupivacaine as alternative agents in chronic epidural infusions for intractable non-cancer pain
39. Intraspinal narcotic tolerance: Preliminary experience with continuous bupivacaine HCl infusion via implanted infusion device
40. A double-blind randomised comparison of the effects of epidural clonidine, lignocaine and the combination of clonidine and lignocaine in patients with chronic pain
41. Epidural clonidine analgesia for intractable cancer pain
42. Intrathecal morphine and clonidine in the management of spinal cord
43. The stability of morphine in isobaric and hyperbaric solutions in a drug delivery system
44. Stability of morphine hydrochloride in a portable pump reservoir
45. Alternated delta and mu receptor activation: A strategem for limiting opioid tolerance
46. Differences in efficacies between morphine and methadone demonstrated in guinea pig ileum
47. Practical issues in the management of cancer pain
48. Pharmacokinetics and pharmacodynamics of morphine-3-glucuronide in rats and its influence on the antinociceptive effect of morphine
49. Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: Relationship to renal function and route of administration
50. Urinary excretion of hydromorphone and metabolites in humans, rats, dogs, guinea pigs and rabbits
51. Hydromorphone metabolite accumulation in renal failure
52. Endocrine consequences of long-term intrathecal administration of opioids
53. Altered sexual function and decreased testosterone in patients receiving intraspinal opioids
54. Comparative efficacy of patient-controlled administration of morphine, hydromorphone, or sufentanil for the treatment of oral mucositis pain following bone marrow transplantation
55. Clinical realities and economic considerations: Economics of intrathecal therapy
56. Spinal opioid infusions in the treatment of chronic pain of nonmalignant origin
57. Comparative reliability and validity of chronic pain intensity measures
58. Comparison of verbal and visual analogue scales for measuring the intensity and unpleasantness of experimental pain